Validity of new methods to evaluate renal function in cancer patients treated with cisplatin

PURPOSE: Creatinine clearance (Ccr) is used as a marker of renal function in cancer chemotherapy, but it is not correlated with glomerular filtration rate (GFR) after high-dose cisplatin treatment. In addition to Ccr, measured using 24-h urine collection (24-h Ccr) or Cockcroft–Gault formula (CGF),...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Chemother Pharmacol
Autors principals: Funakoshi, Yohei, Fujiwara, Yutaka, Kiyota, Naomi, Mukohara, Toru, Shimada, Takanobu, Toyoda, Masanori, Imamura, Yoshinori, Chayahara, Naoko, Tomioka, Hideo, Umezu, Michio, Otsuki, Naoki, Nibu, Ken-ichi, Minami, Hironobu
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747994/
https://ncbi.nlm.nih.gov/pubmed/26791871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-016-2966-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars